530317.BO Stock Analysis
53
Avoid
Based on Eyestock quantitative analysis, 530317.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Godavari Drugs Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. The company is headquartered in Secunderabad, Telangana. The firm also has active loan licenses and contract manufacturing tie-ups with multinational companies for API’s and drug intermediates. The company serves the global life science industry. Its API products offering includes Ciprofloxacin HCl USP/EP/BP/IP, Ciprofloxacin (Base) USP/EP/BP/IP, Ciprofloxacin Lactate IH, Ciprofloxacin Betaine IH, Mefenamic Acid USP/EP/BP/IP, Enrofloxacin USP/EP/BP/IP and Elthambutoal HCI USP/BP/IP. Its intermediates include A D Lactone (for Spironolactone) and 6 Mercaptopurine (for Azathioprine). The firm's manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The facility has multiple production blocks for API’s, drug intermediates and fine chemicals.